Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children.
about
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of ageEffectiveness of antiretroviral therapy in HIV-infected children under 2 years of ageLongitudinal changes in regional fat content in HIV-infected children and adolescents.Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda.Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern IndiaMitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhoodPathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS.Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural UgandaNutritional status and lipid profile of HIV-positive children and adolescents using antiretroviral therapy.Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapyBody fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.Antiretroviral therapy and mother-to-child transmission of HIV-1.Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.A.S.P.E.N. clinical guidelines: nutrition support of children with human immunodeficiency virus infection.HIV-associated lipodystrophy syndrome: A review of clinical aspects.Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors.Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.Metabolic complications and treatment of perinatally HIV-infected children and adolescents.Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.Growth and puberty in children with HIV infection.Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients.Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.Body composition in prepubertal, HIV-infected children: a comparison of bioelectrical impedance analysis and dual-energy X-ray absorptiometry.Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.PENTA guidelines for the use of antiretroviral therapy, 2004.Evolution of lipid levels in HIV-infected children treated or not with HAART in Abidjan, Cote d'Ivoire.Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.Effects of highly active antiretroviral therapy on paediatric metabolite levels.Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome.Indices of whole-body and central adiposity for evaluating the metabolic load of obesityLow prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study
P2860
Q24194589-694DE63F-4244-4460-85CF-83AAB35C04FBQ24202004-5767158F-08EB-4BA3-BF74-2D73CDD61EAAQ33693051-E62C7349-3FED-4365-916A-33BA67B1ABE2Q33972150-33AA3F20-F956-4080-9180-DBA9E9478103Q34335535-E63606A2-DC83-42FC-A0D0-8D30ABA7B5A9Q34464649-A50C27F8-FDCF-419B-AC30-4A4E8B1211F1Q34495072-6592ECE4-E558-41AE-B440-16771544AAFAQ34650866-225C042D-96F8-4682-B71A-FF0B31EE8203Q34760550-5EC84288-88B6-48E6-AD9A-2710C59E478BQ35009569-D685ECF0-42F4-4C3D-B9C9-1E10586259CBQ35087195-6A505A42-D9A0-4E70-9C23-5CD2696C0997Q35093189-056D7E5A-2924-495A-9B5D-FD2CC9E81B5CQ35205900-55E335D4-BDBE-4F96-A49B-B0F10266B082Q35656425-077C2000-857E-47BD-9A52-E38EEAFF16B9Q35917533-CDEC56C2-FF37-4212-B809-915C739B3AF3Q35926011-7448DD6A-9A11-48AD-AA18-E706806E2759Q35945312-06737614-A81C-4CEA-A1C0-001F8484C9A6Q36004865-F07A3E8C-7DC0-4C56-9A77-A7CCFE3ABF8AQ36171069-7AA9DDA4-0304-4D4F-92A6-60A0CDAA3350Q36206201-E2244AD0-6096-4141-AB07-E3D349E76B2AQ36386822-AB66BB9D-B6B0-425D-BD48-AC057302605FQ36952291-FB2070CA-1F7E-4EEA-AB67-14F506CDDBA2Q37016598-21A1A7CA-1BD2-4D52-9BDC-D852E8299F16Q37428510-0365DFFD-9BD8-402D-BB2A-96D0FA3AD7FAQ37435125-A44872A5-DB9B-4A50-84E4-904D3C510F23Q37676229-EC12AA9A-761E-4B1A-9AF9-A149718FB92FQ40579729-CE1CC2E2-3FB5-4FDF-9904-3EB787BDFB3CQ42273064-B217CE39-C3DA-4121-8EDF-11065665F774Q43871655-B50284D0-8A8A-4109-A12D-B637D321CB45Q44263320-E5DEBA77-C2F4-4739-8125-475724699D4AQ44355459-9799B4E3-18C3-450D-BE4B-D3DA34424B1CQ44551426-66F15FA4-4B7B-4934-B96C-EFB13F3A57C0Q46824216-5DD0154B-679A-41DD-8ED9-A1D685D069ECQ51494133-CC559706-4BA9-4143-863A-0498CA997E3FQ56783736-1A7CCBEC-FCE4-4CBD-9C90-04CA96BB300AQ58798902-94AAFD29-9914-4FAF-8A9B-8E8A9A02A576
P2860
Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Clinical and metabolic present ...... rome in HIV-infected children.
@en
Clinical and metabolic present ...... rome in HIV-infected children.
@nl
type
label
Clinical and metabolic present ...... rome in HIV-infected children.
@en
Clinical and metabolic present ...... rome in HIV-infected children.
@nl
prefLabel
Clinical and metabolic present ...... rome in HIV-infected children.
@en
Clinical and metabolic present ...... rome in HIV-infected children.
@nl
P2093
P1433
P1476
Clinical and metabolic present ...... rome in HIV-infected children.
@en
P2093
Lévy-Marchal C
Ortega-Rodriguez E
P304
P356
10.1097/00002030-200009290-00008
P407
P577
2000-09-01T00:00:00Z